Zura Bio Limited, a clinical-stage immunology company, has appointed Robert Lisicki as Chief Executive Officer and Director of the Board at Zura Bio.   Lisicki succeeds Founding CEO, Dr. Someit Sidhu, who will remain involved as a board member, offering continued guidance. Lisicki has extensive experience in the pharmaceutical industry, having held key leadership positions at pharmaceutical organizations of various sizes. Experience Lisicki recently served as President and Chief Operating...